Member Info for Jace86

I certainly wouldn't want to pay for it in its current format.

I regularly read publications from various news outlets that use reach but really find it frustrating to click on an article to read to only have to click on a button to continue reading and then have the entire user experience decimated by poorly loaded adverts and scrolling. No amount of promise to remove said experience would convince me to cough up.

I often close the thing in annoyance. If I was an advertiser paying for this, I'd be asking are users seeing the ads from traffic or acting like I do and closing their browsers?

Disclosure: I currently don't hold a position. It is on my watch list though to look for improvements that could see growth.

If no direct contact company needs to interrogate nominees imo.

Someone mentioned takeover. Would you really want it to go on the cheap?

If funds are in nominee accounts they aren't obliged.

The nominee holder will declare if their volume changes. ONLY in an instance where they may be subject to investigations would an application be made for disclosure. Sometimes a company may itself undertake this process under section 793 notice to the nominee account holder. Some may do this as an auditing process.

Outside of nominee accounts they are obliged but subject to limitations summarised below by Neil. I wasn't clear in my original post on obligations.

There's no obligation to TR1. Sometimes it just doesn't happen.

Would be nice to get one.

Can take a few days to come through if one does arrive though.

But it's not 'China' though. Look at the names of the companies involved. They wouldn't destroy their own reputations by doing that.

Haha

4.12% of the company equity approx.

Spot on robspu

I meant tight not right... Autocorrect...

Dan - over the years I suspect a lot of false floors and false ceilings. So orders in either direction that force the price.

Actual stock has always been right it's worth noting. Possibly why orders are placed and then likely cancelled too.

Off small buys too.

If we can hold it now and bring any news along with the rise.

I'm here for the end game so not interested in selling. Suspect there's a few more with good sized holds like that too.

Reads well.

Interesting involvement from Optiva. (I wonder if Corvus will offer anything similar in future to book in their borrow as shares?)

Bottom line now, anything sub 1.8p is a buy.

The sale for the ciz product comes from the capability to direct patients in the correct care pathway.

Grail won't be able to do that and instead will add to backlogs as it detects "something". More invasive examinations.

Anyone with half a brain would want to remove such problems, not add to them.

Grail is still in trial and taking a long time, rolling beyond next year.

We are only going for simple diagnostic and FDA/CE marker on kit to determine a likelihood of an issue.

I'm not worried about Grail one bit.

Also factor in what Neilin wrote about MABs being used for various forms of treatment. I didn't want to mention this and jinx it but it's out there now. Eventually this is also an avenue on top of protein therapies that can reverse engineer expressions and cellular creation from DNA given we can see what's missing now.

Gates and Bezos just basically lobbied politicians for this.

The test is wildly inaccurate. It's a coin toss level odds of detection.

If I was an insurer, I simply wouldn't want it.

If Neil's post is a bit too long for some, I'll summarise in one word.

"Buy"

Lol

Joking aside anyone not here for the long term is a bit silly. By all means take away risk of you choose but I've always said, this isn't a trader.

For China, the companies involved are funding.

I'd hope they would look to extend such agreements for elsewhere as they are multi national companies after all.

Steve, more funding from someone else. We do not need to fund this.

BiffyBoy1982 would be my guess then?

I can oddly see people posting at your new username before this account was created on the old BOU chat. That's odd. Because there's no posts with your name on either.

If you was BiffyBoy I see he was in ODX too... There's a poster in the telegram group that was also in this and isn't keen on the UK testing market. I do wonder if you are one and the same.

I can vouch that Oracle has been here for as long as I have.

You on the other hand oddly are an account created when this came back to market from BOU.

Whatever your claimed motive and if you've "written it off" it still makes no sense why you continually post reasons to sell but do not sell and move on.

Almost as if you are a bitter ex broker...

Dodgy UT trade there at the end... makes it look lower than it should actually be.

Spread is more like 1.56-1.61.

I'd disregard that trade if taking it as an indicator on where the price is currently at.